Back
Cencora, Inc. 10K Form
Sell
27
COR
Cencora, Inc.
Last Price:
$337.59
Seasonality Move:
6.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-07-31 | 10Q | COR/Cencora, Inc. Quarterly |
| 2020-05-01 | 10Q | COR/Cencora, Inc. Quarterly |
| 2020-02-07 | 10K | COR/Cencora, Inc. Annual |
| 2019-11-01 | 10Q | COR/Cencora, Inc. Quarterly |
| 2019-07-26 | 10Q | COR/Cencora, Inc. Quarterly |
| 2019-04-26 | 10Q | COR/Cencora, Inc. Quarterly |
Receive COR News And Ratings
See the #1 stock for the next 7 days that we like better than COR
COR Financial Statistics
Sales & Book Value
| Annual Sales: | $321.3B |
|---|---|
| Cash Flow: | $2.9B |
| Price / Cash Flow: | 20.37 |
| Annual Sales: | $7.78 |
| Price / Book: | 43.13 |
Profitability
| EPS (TTM): | 7.95180 |
|---|---|
| Net Income (TTM): | $1.6B |
| Gross Margin: | $10.1B |
| Return on Equity: | 124.72% |
| Return on Assets: | 2.19% |
Cencora, Inc. Earnings Forecast
Key Cencora, Inc. Financial Ratios
-
The Gross Profit Margin over the past 32 years for COR is 3.16%.
-
The Selling, General & Administrative Expenses for COR have been equal to 2.02% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 26.77% of Operating Income.
-
The Net Earning history of COR is 0.49% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 22 years.
Cencora, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | COR |
| Website: | cencora.com |
Debt
| Debt-to-Equity Ratio: | 6.19 |
|---|---|
| Current Ratio: | 0.9 |
| Quick Ratio: | 0.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 42.12 |
|---|---|
| Forward P/E Ratio: | 17.16 |
COR Technical Analysis vs Fundamental Analysis
Sell
27
Cencora, Inc. (COR)
is a Sell
Is Cencora, Inc. a Buy or a Sell?
-
Cencora, Inc. stock is rated a SellThe current Cencora, Inc. [COR] share price is $335.31. The Score for COR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.